Our top pick for
Onto Innovation Inc is a semiconductors business based in the US. Onto Innovation shares (ONTO) are listed on the NYSE and all prices are listed in US Dollars. Onto Innovation employs 1,247 staff and has a trailing 12-month revenue of around USD$556.5 million.
|52-week range||USD$20.32 - USD$66.95|
|50-day moving average||USD$59.8271|
|200-day moving average||USD$43.3154|
|Wall St. target price||USD$71.4|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.2436|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Onto Innovation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Onto Innovation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Onto Innovation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 520x. In other words, Onto Innovation shares trade at around 520x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Onto Innovation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$104.9 million.
The EBITDA is a measure of a Onto Innovation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$556.5 million|
|Operating margin TTM||6.71%|
|Gross profit TTM||USD$289.1 million|
|Return on assets TTM||1.6%|
|Return on equity TTM||2.45%|
|Market capitalisation||USD$3.1 billion|
TTM: trailing 12 months
There are currently 1.4 million Onto Innovation shares held short by investors – that's known as Onto Innovation's "short interest". This figure is 17.7% down from 1.7 million last month.
There are a few different ways that this level of interest in shorting Onto Innovation shares can be evaluated.
Onto Innovation's "short interest ratio" (SIR) is the quantity of Onto Innovation shares currently shorted divided by the average quantity of Onto Innovation shares traded daily (recently around 362477.72020725). Onto Innovation's SIR currently stands at 3.86. In other words for every 100,000 Onto Innovation shares traded daily on the market, roughly 3860 shares are currently held short.
However Onto Innovation's short interest can also be evaluated against the total number of Onto Innovation shares, or, against the total number of tradable Onto Innovation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Onto Innovation's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Onto Innovation shares in existence, roughly 30 shares are currently held short) or 0.0357% of the tradable shares (for every 100,000 tradable Onto Innovation shares, roughly 36 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Onto Innovation.
Find out more about how you can short Onto Innovation stock.
We're not expecting Onto Innovation to pay a dividend over the next 12 months.
Onto Innovation's shares were split on 28 October 2019. This wouldn't directly have changed the overall worth of your Onto Innovation shares – just the quantity. However, indirectly, the new INF% higher share price could have impacted the market appetite for Onto Innovation shares which in turn could have impacted Onto Innovation's share price.
Onto Innovation Inc. engages in the design, development, manufacture, and support of process control tools that performs macro defect inspection and metrology, lithography systems, and process control analytical software worldwide. It offers process and yield management solutions, and device packaging and test facilities through standalone systems for macro-defect inspection, packaging lithography, probe card test and analysis, and transparent and opaque thin film measurements; and process control software portfolio that includes solutions for standalone tools, groups of tools, or factory-wide suites. The company also provides spare parts and software licensing services. Its products are used by semiconductor wafer and advanced packaging device manufacturers; silicon wafer; light emitting diode; vertical-cavity surface-emitting laser; micro-electromechanical system; CMOS image sensor; power device; RF filter; data storage; and various industrial and scientific applications. The company was formerly known as Rudolph Technologies, Inc. Onto Innovation Inc. was founded in 1940 and is headquartered in Wilmington, Massachusetts.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.